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Abstract
Objective To evaluate the efficacy of cognitive behaviour
therapy for adolescents aged 10-17 years with chronic fatigue
syndrome.
Design Randomised controlled trial.
Setting Department of child psychology.
Participants 71 consecutively referred patients with chronic
fatigue syndrome; 36 were randomly assigned to immediate
cognitive behaviour therapy and 35 to the waiting list for
therapy.
Intervention 10 sessions of therapy over five months.
Treatment protocols depended on the type of activity pattern
(relatively active or passive). All participants were assessed again
after five months.
Main outcome measures Fatigue severity (checklist individual
strength), functional impairment (SF-36 physical functioning),
and school attendance.
Results 62 patients had complete data at five months (29 in the
immediate therapy group and 33 on the waiting list). Patients in
the therapy group reported significantly greater decrease in
fatigue severity (difference in decrease on checklist individual
strength was 14.5, 95% confidence interval 7.4 to 21.6) and
functional impairment (difference in increase on SF-36 physical
functioning was 17.3, 6.2 to 28.4) and their attendance at school
increased significantly (difference in increase in percentage
school attendance was 18.2, 0.8 to 35.5). They also reported a
significant reduction in several accompanying symptoms. Self
reported improvement was largest in the therapy group.
Conclusion Cognitive behaviour therapy is an effective
treatment for chronic fatigue syndrome in adolescents.
Introduction
Patients with chronic fatigue syndrome have debilitating
unexplained severe fatigue that is not the result of an organic
disease or ongoing exertion and is not alleviated by rest. Symp-
toms last for at least six months and are accompanied by other
symptoms like muscle pain and unrefreshing sleep.1 2 This
condition can occur in adults and adolescents.3
Several randomised controlled trials have shown that cogni-
tive behaviour therapy is effective in adults.4 5 To date, however,
there have been no published controlled studies on such therapy
for adolescents, though one uncontrolled study suggested that
such a behavioural approach can reduce fatigue in adolescents.6
Development of potentially effective interventions is especially
important in young people to avoid prolonged absence from
school and restricted social activities, which threaten healthy
development.7–9
Methods
We studied the efficacy of cognitive behaviour therapy for
adolescents with chronic fatigue syndrome by comparing
outcome in those randomly assigned to immediate therapy with
outcome in those who were assigned to the waiting list for
therapy. We used two treatment protocols: one for patients with
a passive physical activity pattern and one for relatively active
patients.4 10 11
We hypothesised that fatigue severity, functional impairment,
and school absence would decrease significantly more in those
assigned to immediate therapy.
Patients
As part of the usual care all consecutive patients with a major
complaint of fatigue referred to the paediatrics outpatient clinic
between October 1999 and October 2002 were assessed by
means of a detailed history and physical and laboratory
examinations. Patients were eligible if they were between 10 and
17.2 years of age (to allow the older participants to complete
therapy before their 18th birthday) and met the US Centres for
Disease Control Prevention criteria for chronic fatigue
syndrome.1 Severe fatigue and severe functional impairment
were defined as a score of 40 or more on the fatigue severity sub-
scale of the checklist individual strength4 and a weighted score of
65 or less on the SF-36 physical functioning subscale. We
excluded patients with psychiatric comorbidity, as assessed
during an interview with both patients and parents by an experi-
enced child psychologist before randomisation.
Design and procedures
We gave patients and their parents verbal and written
information about the study and obtained informed consent
before randomisation. Before baseline assessments, patients
were randomly allocated to one of the two groups by means of a
sequence of labelled cards contained in sealed numbered
envelopes that were prepared by a statistical adviser and opened
by the researcher in the presence of patient and parent(s). The
randomisation sequence was based on a table of random
numbers. The same researcher performed the allocation proce-
dure and data analyses.
Patients assigned to immediate therapy had to agree to not
having any further medical examinations or other treatments for
fatigue during therapy.4 Patients assigned to the waiting list were
assessed directly after randomisation and five months later. No
further requirements were made during the waiting period, and
they were free to have other examinations or treatments. They
were informed beforehand that, if desired, they could start
therapy directly after the second assessment.
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Intervention
The therapy comprised 10 individual sessions over five months.
We used two treatment protocols based on the existing protocols
for adults and adapted for the two types of patterns of physical
activity.4 11 Adolescents with a relatively active physical activity
pattern alternate between periods of activity and periods of
rest.11 In contrast, those with a passive physical activity pattern
spend most time lying down and go out infrequently. Most do
not attend school at all.
Active patients—For relatively active patients treatment started
with them learning to recognise and accept their current state of
fatigue and impairment. Subsequently, they reduced their levels
of activity and learnt to respect the limitations. After achieving
this balance, the patient started to build up activity levels. This
protocol was used in the trial of Prins et al.4
Passive patients—For passive patients we started a systematic
programme of activity building as soon as possible. To assure
adherence, we first addressed and challenged their beliefs that
activity would aggravate symptoms. In such patients it is thought
to be counterproductive to reduce activity levels any further or
reinforce the patient’s need to respect limitations.11
All therapy—Both protocols differed from the treatment of
adults. Firstly, we actively involved parents in supporting their
child and explored and addressed parents’ beliefs and
behaviours regarding the condition of their child. Secondly, the
aims of therapy took into account the specific developmental
tasks of adolescents. In children younger than 15 years, parents
often acted as a coach; for older participants, parents had to step
back and encourage their child to take responsibility for the
treatment. Thirdly, return to full time education was always a goal
of treatment, and a plan for returning to school was discussed
early with everyone involved. Four child therapists who were
trained and supervised by an experienced cognitive behavioural
therapist administered all therapy.
Primary outcome variables
We measured fatigue with the fatigue severity subscale of the
checklist individual strength, a questionnaire originally devel-
oped for adults.4 12 13 Internal consistency was excellent, with a
Chronbach’s  of 0.93.We measured functional impairment with
the “physical functioning” subscale of the SF-36 (range 0 (maxi-
mum physical limitation) to 100 (ability to do vigorous activity)).
This measure is reliable and valid and has been used in
adolescents with chronic fatigue syndrome.14 15 School attend-
ance was calculated by dividing the hours that the patient
attended lessons in the previous week by the hours that the
patient should have attended.
Other outcome variables
We rated the presence of nine symptoms (see table 3 below) on a
4 point Likert scale (from never to every day).1 Patients indicated
whether they were completely recovered, felt much better, had
the same complaints, or had become worse than at the previous
assessment.4 16 We measured physical activity with an actometer,
a motion sensing device attached to the ankle and worn continu-
ously for 12 days.10 Patients were classified by comparison of
daily activity scores with the reference score of adults with
chronic fatigue syndrome. Pervasively passive patients had an
average daily activity score below this reference score on 11 or 12
of a total of 12 days. All other patients were considered to be
relatively active.4 10 17
Analysis
Power calculations showed that we needed 30 patients in each
group to achieve 90% power to detect a difference of 7 points on
the fatigue severity subscale with an  < 5% (two tailed).18 We
used SPSS (version 10.0) for all statistical analyses. Effects were
tested at the P < 0.05.
We analysed data on an intention to treat basis and carried
forward last observations in cases of missing data. Differences
between groups on the amount of change in the primary
outcome variables were calculated with analyses of variance on
differences in scores before and after the five months, with 95%
confidence intervals. We defined patients as having clinically sig-
nificant improvement if they had a reliable change index > 1.96
and a fatigue score < 35.7 (1 SD above the mean for 420 healthy
adolescents, unpublished data) for fatigue severity19; had an
increase of ≥ 50 or an end score of ≥ 75 for physical
functioning20; were fully attending school at the five months
assessment; and reported “I have completely recovered” or “I feel
much better.” We used 2 tests to assess differences between the
proportions of patients meeting these criteria.
Results
The figure shows the trial profile. Seventy one patients were ran-
domly allocated to either immediate therapy (n = 36) or to
remain on the waiting list (n = 35). After randomisation we
excluded two patients (one from each group) because the
diagnosis of chronic fatigue syndrome was incorrect. Analyses
were based on the 69 remaining patients. Of those, 29 in the
immediate therapy group and 33 from the waiting list completed
the assessment at five months. Six patients dropped out during
the course of treatment, three of them did not finish the second
assessment. Table 1 shows the baseline characteristics of both
groups.
Effect of intervention
Primary outcome—Patients in the immediate therapy group
reported a significantly greater decrease in fatigue severity
(difference in decrease on checklist individual strength 14.5, 95%
confidence interval 7.4 to 21.6) and functional impairment (dif-
ference in increase on SF-36 physical functioning 17.3, 6.2 to
28.4) than patients on the waiting list. School attendance also
increased significantly more in the therapy group (difference in
increase in school attendance 18.2, 0.8 to 35.5) (table 2).
Other outcomes—At five months the participants in the therapy
group reported a significantly greater decrease in how often they
felt ill after exercise, impaired concentration, unrefreshing sleep,
muscle pain, and headache (table 3). Patients on the waiting list
reported increased prevalence of impaired concentration, unre-
freshing sleep, and muscle pain.
Clinically significant improvement—For all primary outcome
variables as well as for self rated improvement the proportion of
patients with clinically significant improvements was greatest
among those in the therapy group (table 4).
Two treatment protocols—There were no significant differences
in all primary outcomes between adolescents who were treated
with the protocol designed for patients with a passive physical
activity pattern and those who were treated with the protocol for
more active patients (table 5).
Discussion
In adolescents with chronic fatigue, cognitive behaviour therapy
was more effective than remaining on a waiting list in reducing
severity of fatigue, improving physical functioning, and
increasing school attendance. Furthermore, treatment resulted
in a greater proportion of patients with clinically significant
change in these variables, more self reported improvement, and
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a significant reduction in several additional symptoms. These
results endorse the findings of previous studies on the efficacy of
cognitive behaviour therapy for adults with chronic fatigue syn-
drome.4 5 Passive and active patients showed equal improve-
ments on all primary outcome variables. Furthermore, rates of
improvement were larger than seen in the study by Prins et al, in
which only one protocol was used to treat all patients.4
We tried to maximise inclusion by repeatedly informing gen-
eral practitioners and paediatricians about the study and
prolonging recruitment. Nevertheless, our final samples were
still relatively small. This may be due to underdiagnosis because
of unfamiliarity with adolescent chronic fatigue syndrome or
may point to reluctance in doctors to diagnose this syndrome.
Alternatively, chronic fatigue syndrome may be less common
than previously estimated.3 We believe that our results can be
generalised to other adolescents who fulfil the diagnostic criteria
for chronic fatigue syndrome as our patients were referred from
a large part of the Netherlands.
Six patients (19%) withdrew from therapy, which is higher
than in most adult studies on cognitive behaviour therapy in
patients with chronic fatigue syndrome.5 Most withdrawals
occurred in the first half of the study, suggesting that therapists
became more experienced in meeting the specific need for
enhancing motivation of adolescent patients. As we did not have
reference scores for activity pattern in adolescents, we used
scores for adults. Fortunately, our results showed that mean
Patients referred (n=113)
Randomised (n=71)
Assigned CBT (n=36)
Completed assessment at 5 months (n=29)
Eligible to enter trial (n=82)
Not eligible (n=31):
 Too little functional impairments (n=24)
 Too old (n=3)
 Lifelong fatigue (n=1)
 Medical explanation for fatigue (n=1)
 Physical comorbidity (n=1)
 Duration <6 months (n=1)
Non-participants (n=11):
 Not necessary, doing better according
  to patient (n=2)
 Other therapy (n=4)
 Too strenuous (n=2)
 Distance (n=1)
 Final exams (n=1)
 No reason (n=1)
Did not complete assessment
  at 5 months (n=7):
 Excluded from trial (n=1)
 Not starting therapy (n=3)
 Withdrew (n=3)
Assigned waiting list condition (n=35)
Completed assessment at 5 months (n=33)
Did not complete assessment
  at 5 months (n=2):
 Excluded from trial (n=1)
 Withdrew (n=1)
Trial profile
Table 1 Baseline characteristics of study participants. Values are means
(SD) unless stated otherwise
Cognitive behaviour therapy
(n=35) Waiting list (n=34)
Demography
Age (years) 15.6 (1.3) 15.7 (1.3)
Median duration of complaints
(months)
16.0 18.0
No (%) female 31/35 (89) 31/34 (91)
Primary outcome variables
Fatigue severity (checklist
individual strength)
52.5 (3.8) 51.6 (4.3)
Physical functioning (SF-36) 42.1 (16.5) 45.3 (17.0)
No (%) with school attendance:
Full 4/35 (11) 6/34 (18)
Partial 31/35 (89) 28/34 (82)
Physical activity pattern (No (%))
Pervasively passive 10/33* (30) 7/34 (21)
Relatively active 23/33* (70) 27/34 (79)
*Two participants refused to wear an actometer.
Table 2 Effect of cognitive behaviour therapy on fatigue severity, functional impairment, and school attendance
Condition*
Mean score (SD)
Treatment effect† (95% CI) P value0 months 5 months
Fatigue severity
Cognitive behaviour 52.5 (3.8) 30.2 (16.8) 14.5 (7.4 to 21.6) 0.001
Waiting list 51.6 (4.4) 44.0 (13.4)
Physical functioning
Cognitive behaviour 42.1 (16.5) 69.4 (28.0) 17.3 (6.2 to 28.4) 0.003
Waiting list 45.3 (17.0) 55.3 (21.1)
School attendance
Cognitive behaviour‡ 46.2 (38.9) 74.7 (37.8) 18.2 (0.8 to 35.5) 0.040
Waiting list 56.4 (38.6) 66.7 (36.0)
*Cognitive behaviour therapy n=35; waiting list n=34.
†Difference in improvement between intervention and control group.
‡Two participants were left out of analyses because they had taken their final examinations and therefore were not required to attend school at five months.
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activity levels and distributions of types of activity were similar to
those in adults. Thus the use of reference scores for adults should
not have led to misclassification.
Almost 60% of the patients in the immediate therapy group
returned to full time education, an important indication of
recovery. We consider that return to school is most difficult when
adolescents lose contact with school and classmates and experi-
ence longstanding social isolation. In these cases other possibili-
ties to guarantee education should be explored, such as
considering a new school.
The prevalence of additional symptoms decreased signifi-
cantly in immediate treatment group. Nevertheless, as in a previ-
ous report,21 many young people in both groups continued to
report additional symptoms. Apparently, a complete resolution
of additional symptoms is not a requirement of recovery, as has
been suggested before.22
This study is the first randomised controlled trial to show that
cognitive behaviour therapy can successfully be used to treat
adolescents with chronic fatigue syndrome. As the prevalence of
chronic fatigue syndrome seems to be lower than previously
thought, we would not recommend widespread implementation
of cognitive behaviour therapy but suggest that treatment should
be centralised in specialised medical centres so that therapists
can accumulate knowledge and maintain proficiency.
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Table 3 Effects of treatment on the prevalence of additional symptoms according to the Centers of Disease Control criteria. Values are means (SD)
Condition*
Symptom score†
Treatment effect (95% CI) P value0 months 5 months
Unrefreshing sleep
Cognitive behaviour 3.4 (1.0) 2.5 (1.1) −1.2 (−1.8 to −0.6) 0.001
Waiting list 2.7 (0.6) 3.2 (0.8)
Muscle pain
Cognitive behaviour 2.7 (1.1) 2.4 (1.0) −1.1 (−1.6 to −0.6) 0.001
Waiting list 1.8 (0.9) 2.7 (0.8)
Impaired concentration
Cognitive behaviour 2.9 (1.1) 2.4 (1.2) −1.1 (−1.5 to −0.65) 0.001
Waiting list 2.0 (0.9) 2.7 (0.8)
Tiredness after exercise
Cognitive behaviour 3.5 (0.7) 2.5 (1.1) −1.0 (−1.5 to −0.5) 0.001
Waiting list 2.8 (0.3) 2.9 (0.3)
Headache
Cognitive behaviour 2.9 (0.8) 2.6 (0.9) −0.05 (−0.9 to 0.0) 0.033
Waiting list 2.3 (0.9) 2.5 (0.8)
Impaired memory
Cognitive behaviour 2.1 (1.2) 1.8 (1.1) −0.4 (−0.93 to 0.1) 0.12
Waiting list 2.2 (1.0) 2.4 (1.0)
Multi-joint pain
Cognitive behaviour 2.5 (1.2) 2.0 (1.2) −0.2 (−0.7 to 0.3) 0.38
Waiting list 2.6 (0.6) 2.3 (0.9)
Sore throat
Cognitive behaviour 1.8 (0.8) 1.6 (0.8) 0.2 (−0.3 to −0.7) 0.40
Waiting list 2.3 (0.8) 1.9 (0.7)
Sensitive lymph nodes
Cognitive behaviour 1.8 (1.0) 1.6 (0.9) 0.0 (−0.4 to 0.6) 0.72
Waiting list 1.8 (0.9) 1.5 (0.9)
*Cognitive behaviour therapy n=35; waiting list n=34.
†Symptoms rated on 4 point Likert scale (never to every day), range 1 to 4.
Table 4 Clinically significant improvement at five months in fatigue severity
(checklist individual strength), functional impairment (SF-36), and school
attendance (mean percentage) and self rated improvement by treatment
group
Condition No (%) improved Treatment effect (95% CI) P value
Fatigue severity*
Cognitive behaviour 21/35 (60) 0.39 (0.17 to 0.61) 0.01
Waiting list 7/34 (21)
Physical functioning†
Cognitive behaviour 22/35 (63) 0.39 (0.17 to 0.61) 0.01
Waiting list 8/34 (24)
Full school attendance‡
Cognitive behaviour 19/33 (58) 0.29 (0.06 to 0.53) 0.02
Waiting list 10/34 (29)
Self rated improvement§
Cognitive behaviour 25/35 (71) 0.27 (0.04 to 0.78) 0.02
Waiting list 15/34 (44)
*Reliable change index >1.96 and cut off score of ≥35.7.
†Increase of ≥50 or end score of ≥75.
‡Two participants were left out of analyses because they had taken their final examinations
and therefore were not required to attend school at five months.
§Answer “yes” to statement “I have completely recovered” or “I feel much better but still
experience some symptoms.”
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What is already known on this topic
Cognitive behaviour therapy is an effective treatment for
chronic fatigue syndrome in adults, and one uncontrolled
study has shown that it can reduce fatigue in adolescents
Chronic fatigue syndrome in adolescents can affect normal
development
What this study adds
A cognitive behaviour therapy programme based on
gradually increasing activity and challenging perpetuating
beliefs helped adolescents with chronic fatigue syndrome
Relatively active patients as well as those with a passive
physical activity pattern benefited from tailored therapy
Amendment
The numbers in the abstract have been altered for clarity.
Under participants, the total number randomised (71) has
been given, rather than the number after exclusions (69). In
the results section, the number 58 has been corrected to 62.
Table 5 Treatment effects on fatigue severity (checklist individual strength), functional impairment (SF-36), and school attendance (mean percentage) by
activity pattern in patients assigned to cognitive behaviour therapy
Activity* pattern
Mean score (SD)
Mean difference within groups (95% CI) Mean difference between groups (95% CI) P value0 months 5 months
Fatigue severity
Passive 52.4 (4.2) 35.0 (19.0) −17.4 (−30.1 to –4.7) 8.9 (−3.3 to 21.1) 0.147
Active 52.6 (3.9) 26.3 (14.8) −26.3 (−32.8 to –19.8)
Physical functioning
Passive 37.0 (17.8) 59.0 (35.7) 22.0 (4.7 to 39.3) 10.0 (−3.3 to 21.1) 0.336
Active 43.5 (14.8) 75.4 (23.0) 32.0 (20 to 43.4)
School attendance
Passive 21.0 (35.2) 54.1 (44.6) 33.1 (5.8 to 60.4) 4.1 (−29.0 to 37.3) 0.801
Active 59.7 (35.2) 88.7 (26.1) 29.0 (10.2 to 47.8)
*Passive n=10; active n=23.
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